Studies on the Metabolic Fate of Amrubicin Hydrochloride (SM-5887), a Novel Antitumor Agent. (III): Blood Concentration, Distribution, Metabolism and Excretion After a Single Intravenous Administration to Dogs.
Drug Metabolism and Pharmacokinetics
doi 10.2133/dmpk.13.91
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1998
Authors
Publisher
Japanese Society for the Study of Xenobiotics